Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke

Completed

Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to evaluate the safety and tolerability of SA4503 in patients recovering from a recent stroke. Secondary, to evaluate the efficacy of SA4503 compared to placebo.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 July 2009.

1 Feb 2008 14 Mar 2008 1 Jun 2009 Unavailable 1 Jul 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions See All

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Roman Urfer, PhD 1st Contact Email: roman.urfer@ms-science.com 2nd Contact: Kazumasa Takao, PhD 2nd Contact email: ktakao@m-sci.com

    roman.urfer@ms-science.com